| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$6,177 ) |
| | 2024 | 2022 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15CA274603 | Epitranscriptomic control of ROS | 000 | 1 | NIH | 4/16/2024 | $0 |
| | 2024 | 2021 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 4 | NIH | 7/22/2024 | -$3,442 |
| | 2024 | 2021 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 001 | 4 | NIH | 7/22/2024 | -$1,941 |
| | 2024 | 2020 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 000 | 2 | NIH | 3/28/2024 | -$794 |
|
| Issue Date FY: 2023 ( Subtotal = $296,886 ) |
| | 2023 | 2023 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15CA274603 | Epitranscriptomic control of ROS | 001 | 1 | NIH | 7/17/2023 | $296,920 |
| | 2023 | 2022 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15CA274603 | Epitranscriptomic control of ROS | 000 | 1 | NIH | 11/30/2022 | $0 |
| | 2023 | 2021 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 001 | 4 | NIH | 1/5/2023 | $0 |
| | 2023 | 2021 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 4 | NIH | 1/5/2023 | $0 |
| | 2023 | 2020 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 000 | 2 | NIH | 9/9/2023 | $0 |
| | 2023 | 2019 | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15ES023685 | Genomic profiling of yeast resistance to heterocyclic aromatic amine | 000 | 3 | NIH | 8/23/2023 | -$34 |
|
| Issue Date FY: 2022 ( Subtotal = $459,347 ) |
| | 2022 | 2022 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15CA274603 | Epitranscriptomic control of ROS | 000 | 1 | NIH | 8/24/2022 | $459,347 |
| | 2022 | 2018 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15ES023685 | Genomic profiling of yeast resistance to heterocyclic aromatic amine | 000 | 3 | NIH | 7/25/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $887,040 ) |
| | 2021 | 2021 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 4 | NIH | 12/11/2020 | $510,522 |
| | 2021 | 2021 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 002 | 4 | NIH | 4/16/2021 | $319,793 |
| | 2021 | 2021 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 001 | 4 | NIH | 3/1/2021 | $56,725 |
| | 2021 | 2020 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 001 | 2 | NIH | 6/23/2021 | $284 |
| | 2021 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 000 | 1 | NIH | 6/23/2021 | -$284 |
|
| Issue Date FY: 2020 ( Subtotal = $1,016,850 ) |
| | 2020 | 2020 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 001 | 3 | NIH | 3/11/2020 | $56,725 |
| | 2020 | 2020 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 3 | NIH | 12/17/2019 | $510,522 |
| | 2020 | 2020 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 000 | 2 | NIH | 5/28/2020 | $449,603 |
|
| Issue Date FY: 2019 ( Subtotal = $572,235 ) |
| | 2019 | 2019 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 2 | NIH | 12/13/2018 | $567,247 |
| | 2019 | 2019 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15ES023685 | Genomic profiling of yeast resistance to heterocyclic aromatic amine | 000 | 3 | NIH | 5/8/2019 | $7,982 |
| | 2019 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES026856 | Translational regulation in exposure biology - Xenobiotic-induced reprograming of tRNA modifications and selective translation of codon-biased response genes in rat and human models | 000 | 2 | NIH | 1/29/2019 | -$2,994 |
|
| Issue Date FY: 2018 ( Subtotal = -$397,045 ) |
| | 2018 | 2018 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15ES023685 | Genomic profiling of yeast resistance to heterocyclic aromatic amine | 001 | 3 | NIH | 7/26/2018 | $445,959 |
| | 2018 | 2018 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01GM125870 | Development of a Structurally Interacting RNA (sxRNA) technology | 000 | 1 | NIH | 12/25/2017 | $567,247 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES024615 | Translational Control of ROS Management | 003 | 4 | NIH | 9/22/2018 | -$112,004 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES020867 | Metabolic Mechanisms of Naphthalene Toxicity in Lung | 004 | 6 | NIH | 9/24/2018 | -$12,840 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES020867 | Metabolic Mechanisms of Naphthalene Toxicity in Lung | 002 | 6 | NIH | 4/23/2018 | -$64,008 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES026856 | Translational regulation in exposure biology - Xenobiotic-induced reprograming of tRNA modifications and selective translation of codon-biased response genes in rat and human models | 000 | 2 | NIH | 6/7/2018 | -$307,414 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES024615 | Translational Control of ROS Management | 000 | 4 | NIH | 8/3/2018 | $0 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 12 | NIH | 1/30/2018 | -$358,830 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 003 | 12 | NIH | 4/2/2018 | -$105 |
| | 2018 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES020867 | Metabolic Mechanisms of Naphthalene Toxicity in Lung | 000 | 6 | NIH | 3/19/2018 | -$468,807 |
| | 2018 | 2016 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R21DC013895 | Novel Theranostic Approaches to Identify and Treat Tinnitus Using Functionalized Nanoparticles | 000 | 3 | NIH | 3/7/2018 | -$1,663 |
| | 2018 | 2016 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 002 | 11 | NIH | 4/2/2018 | -$84,580 |
| | 2018 | 2014 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15ES023685 | Genomic profiling of yeast resistance to heterocyclic aromatic amine | 000 | 2 | NIH | 2/23/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $3,167,383 ) (Continued on the next page) |
| | 2017 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R15HL138605 | Role of the Phosphoprotein Phosphatase PTP1B in Cardiac Hypertrophy | 000 | 1 | NIH | 9/1/2017 | $445,959 |
| | 2017 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES026856 | Translational regulation in exposure biology - Xenobiotic-induced reprograming of tRNA modifications and selective translation of codon-biased response genes in rat and human models | 000 | 2 | NIH | 8/11/2017 | $354,362 |
| | 2017 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES024615 | Translational Control of ROS Management | 002 | 4 | NIH | 6/2/2017 | $327,415 |
| | 2017 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 003 | 12 | NIH | 7/12/2017 | $358,935 |
| | 2017 | 2017 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R01ES020867 | Metabolic Mechanisms of Naphthalene Toxicity in Lung | 005 | 6 | NIH | 4/20/2017 | $724,838 |
| | 2017 | 2016 | RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE | 257 FULLER RD | ALBANY | NY | 12203-3613 | ALBANY | USA | R21HG008495 | Trans-Regulation of RNA-Binding Protein Motifs by MicroRNA | 003 | 3 | NIH | 7/31/2017 | -$3 |
|
